Free Trial

Progyny (NASDAQ:PGNY) Shares Up 3.3% - What's Next?

Progyny logo with Medical background
Remove Ads

Shares of Progyny, Inc. (NASDAQ:PGNY - Get Free Report) shot up 3.3% during mid-day trading on Monday . The stock traded as high as $22.66 and last traded at $22.62. 145,917 shares traded hands during trading, a decline of 91% from the average session volume of 1,690,619 shares. The stock had previously closed at $21.90.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on PGNY. JPMorgan Chase & Co. increased their price objective on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a report on Tuesday, January 28th. Canaccord Genuity Group increased their price target on Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research note on Friday, February 28th. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective on the stock in a research note on Monday. Finally, Bank of America raised their price objective on shares of Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $23.64.

Check Out Our Latest Stock Report on PGNY

Progyny Stock Performance

The firm has a 50-day moving average price of $22.18 and a 200 day moving average price of $18.55. The stock has a market capitalization of $1.93 billion, a P/E ratio of 38.97, a price-to-earnings-growth ratio of 2.39 and a beta of 1.33.

Remove Ads

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Mackenzie Financial Corp grew its position in Progyny by 423.8% during the 4th quarter. Mackenzie Financial Corp now owns 117,387 shares of the company's stock worth $2,025,000 after acquiring an additional 94,978 shares during the last quarter. AWM Investment Company Inc. grew its holdings in shares of Progyny by 540.0% in the fourth quarter. AWM Investment Company Inc. now owns 160,000 shares of the company's stock worth $2,760,000 after purchasing an additional 135,000 shares during the last quarter. Voloridge Investment Management LLC increased its stake in shares of Progyny by 85.5% in the fourth quarter. Voloridge Investment Management LLC now owns 1,197,993 shares of the company's stock worth $20,665,000 after buying an additional 552,066 shares during the period. Two Sigma Advisers LP raised its holdings in Progyny by 83.8% during the 4th quarter. Two Sigma Advisers LP now owns 266,100 shares of the company's stock valued at $4,590,000 after buying an additional 121,300 shares during the last quarter. Finally, Two Sigma Investments LP grew its holdings in Progyny by 15.9% in the 4th quarter. Two Sigma Investments LP now owns 657,276 shares of the company's stock worth $11,338,000 after acquiring an additional 90,197 shares during the last quarter. 94.93% of the stock is owned by institutional investors.

About Progyny

(Get Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Recommended Stories

Should You Invest $1,000 in Progyny Right Now?

Before you consider Progyny, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Progyny wasn't on the list.

While Progyny currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads